A bylined article exploring the factors shaping M&A activity in the life sciences sector by EMEA CRO Merlin Piscitelli was published in the September issue of Pharmaceutical Technology Europe. The article highlights how the sector continues to attract investor interest despite unprecedented disruption caused by the pandemic.
Senior Vice President, Finance & Treasury